Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540.
Published March 1, 2017 · Recall initiated: February 2, 2017
Summary
FDA records drug Class II recall D-0481-2017, published March 1, 2017 and initiated February 2, 2017. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 157,922 cartons; Lot: Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Sandoz Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot #: 6323Q11, 6328Q11, Exp 06/19; 6355Q11, Exp 07/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFocalin XR (dexmethylphenidate HCl) 5 mg, 30 extended-release capsules per bottle, Rx only, Manufactured byJune 24, 2026
- FDACyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial,September 24, 2025
- FDACiprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension Rx Only, For Use in Ears Only, Manufactured By:September 17, 2025
- FDACefazolin for Injection, USP, 1 gram per vial, Sterile, For Intramuscular or Intravenous Use, Rx Only,July 9, 2025
- FDAMETRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use,March 1, 2017
- FDAGlipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged byMarch 1, 2017
Questions about this recall
Was Transderm Scop (scopolamine) Transdermal System, 1.5 mg, 1 patch per pouch (NDC 66758-208-58), packaged in 4-count patches per carton (NDC 66758-208-54), Rx Only, Manufactured by ALZA Corporation, Vacaville, CA 95688 for Sandoz Inc., Princeton, NJ 08540. recalled?
Yes. FDA published recall D-0481-2017 on March 1, 2017. Reported hazard: Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating "Do cut the patch" rather than the correct instructions of "Do not cut the patch". The pouch containing the patch is labeled correctly.
What should I do if I have this product?
Voluntary: Firm initiated · Letter